Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Interpace Biosciences
(OTCQX:IDXG)
Intraday
$1.45
-0.02
[-1.36%]
Get Report
Watch
Perks
Buy
Compare Brokers
$1.45
-0.02
[-1.36%]
At close: Apr 19
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Interpace Biosciences Stock (OTC:IDXG)
Interpace Biosciences Stock (OTC: IDXG)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 17, 2021
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021
Benzinga Insights
-
Nov 17, 2021, 10:03AM
HC Wainwright & Co. Downgrades Interpace Biosciences to Neutral
Benzinga Newsdesk
-
Nov 17, 2021, 6:20AM
Tuesday, May 11, 2021
Interpace Diagnostics Gr Q1 Adj. EBITDA Loss $900K vs Loss $4.3M In Same Qtr. Last Year, Sales $9.80M Up From $9.20M YoY
Benzinga Newsdesk
-
May 11, 2021, 4:51PM
Monday, April 12, 2021
Interpace Pharma Solutions Highlights New RNAscope ISH Product
Bill Haddad
-
Apr 12, 2021, 7:16AM
Friday, April 09, 2021
HC Wainwright & Co. Maintains Buy on Interpace Biosciences, Raises Price Target to $9
Benzinga Newsdesk
-
Apr 9, 2021, 7:23AM
Tuesday, March 09, 2021
Interpace Biosciences Reports Expansion Of Relationship With XIFIN To Deploy Revenue Cycle Mgmt. Solution
Benzinga Newsdesk
-
Mar 9, 2021, 9:06AM
Thursday, February 18, 2021
92 Biggest Movers From Yesterday
Lisa Levin
-
Feb 18, 2021, 5:07AM
Wednesday, February 17, 2021
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Feb 17, 2021, 12:54PM
70 Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Feb 17, 2021, 12:19PM
Interpace Biosciences Announces Impending Delisting From Nasdaq; Will Be Suspended At Opening Of Business Feb. 25, 2021
Benzinga Newsdesk
-
Feb 17, 2021, 8:24AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Feb 17, 2021, 8:10AM
Thursday, February 04, 2021
Interpace Biosciences Appoints Tom Freeburg As CFO
Benzinga Newsdesk
-
Feb 4, 2021, 4:48PM
Monday, February 01, 2021
Interpace Biosciences Announces License Agreement With Rutgers University, Mass General Hospital
Benzinga Newsdesk
-
Feb 1, 2021, 9:28AM
Thursday, January 28, 2021
Interpace Diagnostics Shares Halted On Circuit Breaker To Downside, Still Up 19.5% For Session
Benzinga Newsdesk
-
Jan 28, 2021, 9:46AM
Interpace Biosciences Reports Contract For Thyroid Testing With Blue Cross Blue Shield Of Florida, No Terms Disclosed
Benzinga Newsdesk
-
Jan 28, 2021, 9:22AM
Monday, January 25, 2021
HC Wainwright & Co. Maintains Buy on Interpace Biosciences, Lowers Price Target to $6
Benzinga Newsdesk
-
Jan 25, 2021, 8:16AM
Wednesday, January 20, 2021
Interpace Diagnostics Gr Q3 EPS $(1.54) Down From $(0.19) YoY, Sales $8.20M Up From $7.72M YoY
Benzinga Newsdesk
-
Jan 20, 2021, 8:32AM
Tuesday, December 15, 2020
Low Float Momentum Stocks Spiking Higher Over Last Few Mins.: Greenwich Life Sciences, GeoVax, Interpace Biosciences; Not Seeing News To Justify Moves Higher
Benzinga Newsdesk
-
Dec 15, 2020, 11:32AM
Thursday, December 10, 2020
12 Healthcare Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Dec 10, 2020, 4:55PM
Wednesday, December 09, 2020
12 Healthcare Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Dec 9, 2020, 4:44PM
Interpace Biosciences Shares Resume Trading; Move Higher
Benzinga Newsdesk
-
Dec 9, 2020, 2:51PM
Interpace Biosciences Shares Halted On Volatility; Up 14%
Benzinga Newsdesk
-
Dec 9, 2020, 2:47PM
Wednesday, November 25, 2020
Interpace Biosciences Announces Retirement Of President & Chief Executive Jack Stover, Thomas Burnell Appointed As Successor
Benzinga Newsdesk
-
Nov 25, 2020, 8:13AM
Thursday, November 19, 2020
Interpace Biosciences Receives Nasdaq Deficiency Notice Due To Delayed Filing Of Form 10-Q; No Immediate Impact On Listing
Benzinga Newsdesk
-
Nov 19, 2020, 4:13PM
12 Healthcare Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Nov 19, 2020, 8:21AM
60 Biggest Movers From Yesterday
Lisa Levin
-
Nov 19, 2020, 5:01AM
Wednesday, November 18, 2020
12 Healthcare Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Nov 18, 2020, 1:04PM
41 Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Nov 18, 2020, 12:01PM
Interpace Biosciences shares are trading lower after the company said it is unable to file its Form 10-Q for the quarter ended September 30, 2020.
Benzinga Newsdesk
-
Nov 18, 2020, 10:26AM
12 Healthcare Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Nov 18, 2020, 8:08AM
Tuesday, November 03, 2020
54 Biggest Movers From Yesterday
Lisa Levin
-
Nov 3, 2020, 4:53AM
Monday, October 26, 2020
Interpace Biosciences Announces Results of Seminal Clinical Validation Study for Thyroid Assays
Luke J Jacobi
-
Oct 26, 2020, 6:34AM
Thursday, October 22, 2020
HC Wainwright & Co. Maintains Buy on Interpace Biosciences, Lowers Price Target to $10
Benzinga Newsdesk
-
Oct 22, 2020, 6:38AM
Wednesday, October 21, 2020
60 Biggest Movers From Yesterday
Lisa Levin
-
Oct 21, 2020, 5:03AM
Tuesday, October 20, 2020
12 Healthcare Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Oct 20, 2020, 12:54PM
50 Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Oct 20, 2020, 12:00PM
11 Healthcare Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Oct 20, 2020, 8:17AM
Interspace Biosciences shares are trading lower after the company reported worse-than-expected Q2 sales results.
Benzinga Newsdesk
-
Oct 20, 2020, 8:08AM
Interpace Diagnostics Gr Q2 EPS $(1.35) Beats $(1.48) Estimate, Sales $5.45M Miss $5.92M Estimate
Benzinga Newsdesk
-
Oct 20, 2020, 8:05AM
Thursday, October 15, 2020
54 Biggest Movers From Yesterday
Lisa Levin
-
Oct 15, 2020, 4:59AM
Wednesday, October 14, 2020
Why Interpace Biosciences Is Trading Higher Today
Tanzeel Akhtar
-
Oct 14, 2020, 3:49PM
12 Healthcare Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Oct 14, 2020, 1:31PM
44 Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Oct 14, 2020, 12:13PM
Interpace Biosciences shares are trading higher after an audit committee investigation found that billing and compliance complaints against the company were unsubstantiated and that there was no evidence of any illegal acts.
Benzinga Newsdesk
-
Oct 14, 2020, 11:12AM
Mid-Morning Market Update: Markets Open Higher; Goldman Sachs Tops Q3 Expectations
Lisa Levin
-
Oct 14, 2020, 10:14AM
12 Healthcare Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Oct 14, 2020, 8:08AM
Interpace Biosciences Says Audit Committee Investigation Finds Billing And Compliance Complaints Unsubstantiated
Benzinga Newsdesk
-
Oct 14, 2020, 6:33AM
Friday, September 04, 2020
The Daily Biotech Pulse: AbbVie In-licenses I-Mab's Cancer Drug, Savara Pulls The Plug On Cystic Fibrosis Study
Shanthi Rexaline
-
Sep 4, 2020, 7:28AM
Thursday, September 03, 2020
The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax
Shanthi Rexaline
-
Sep 3, 2020, 7:55AM
Wednesday, August 19, 2020
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
Shanthi Rexaline
-
Aug 19, 2020, 7:32AM
Show more